Cell Separation Technology Market Analysis

  • Report ID: 6152
  • Published Date: Sep 17, 2025
  • Report Format: PDF, PPT

Cell Separation Technology Market Segmentation:

End-User Segment Analysis

Research laboratories & institute segment share in the cell separation technology market is set to exceed 53.9% by the end of 2035. Cell separation technology is employed in research laboratories and institutes to conduct tests on isolated cells, execute molecular analysis, modify genetically, and expand a specific cell type for cell therapy research, and disease modeling applications.

Moreover, the prevalence of diseases such as diabetes, and arthritis along with the sudden outbreak of other diseases supports the expansion of the research laboratories & institute segment. As per the estimations of the WHO, over 422 million people across the globe have diabetes, most of them residing in low-and middle-income nations, and 1.5 million deaths are influenced by diabetes each year.  Consequently, these institutions serve as important centers for innovation and cutting-edge research. Owing to this the cell separation technology market is projected to rise over the years to come.

Product Segment Analysis

The consumables & reagents segment in cell separation technology market is predicted to rise gathering the highest revenue by the end of 2035. Consumables and reagents employed for cell separation are essential for numerous uses in life sciences and biomedical research. Consumables comprise media, separation reagents, enrichment solutions, beads, magnets, columns, cells, and others. Their selectivity facilitates the rapid and efficient sorting of cells. Magnetic beads, for instance, coated with antibodies that are particular to cell surface indicators, might be used to isolate target cells when exposed to a magnetic field.

Application Segment Analysis

In cell separation technology market, biomedical segment share is anticipated to reach 70.5% by 2035. Amongst this segment, the cancer research sub-segment is projected to observe significant growth in its revenue. This could be encouraged by growing investment in cancer research. For instance, between 2016 to 2020 over USD 23 billion was funded for cancer research across the globe from about 66,387 public and philanthropic awards.

Our in-depth analysis of the cell separation technology market includes the following segments:

           Product

  • Instruments
  • Consumables & Reagents

             Technology

  • Centrifugation, Affinity Separation
  • Fluorescence-Activated Cell Sorting (FACS)
  • Magnetic-Activated Cell Sorting (MACS)
  • Acoustic Cell Separation
  • Microfluidics, Others

 

 

            Application

  • Biomedical Research
    • Cancer Research
    • Immunology
    • Stem Cell Research
    • Neurobiology
  • Therapeutics
    • Regenerative Medicine
    • Cell Therapy
    • Transplantation
  • Diagnostics
  • Protein Therapeutics Production
  • Others

            End-User

  • Research Laboratories and Institutes
  • Biotechnology and Biopharmaceutical Companies
  • Hospitals and Diagnostic Laboratories
  • Cell Banks

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of cell separation technology is estimated at USD 11.23 billion.

The global cell separation technology market size was more than USD 9.93 billion in 2025 and is anticipated to grow at a CAGR of over 14.5%, reaching USD 38.46 billion revenue by 2035.

North America cell separation technology market achieves a 39.20% share by 2035, driven by increased cell biology research activities and presence of key players.

Key players in the market include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., DH Life Sciences, LLC., Miltenyi Biotec.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos